Flow State Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,300
Closed -$237K 289
2023
Q2
$237K Buy
+2,300
New +$243K 0.09% 88

Other funds holding HZNP

Flow State Investments's HZNP Position: Q4 2023 in Review

Flow State Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 119,935 shares — an estimated $13.9M sold.

Flow State Investments first reported a position in HZNP in Q4 2022 and held it in 4 quarters. The position peaked at $13.9M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Flow State Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Flow State Investments sold 119,935 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $13.9M.
  • Flow State Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 4 quarters.
  • Flow State Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $13.9M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Flow State Investments's 13F filing for Q4 2023, filed 14 Feb 2024.